# Fairtility

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fairtility

- Industry: Software
- Headquarters: Tel Aviv, Israel
- Website: www.fairtility.com
- Total disclosed funding: $15M
- Latest round: Series A (May 23, 2022)
- Investors on record: 2

## About

Founded in 2019 by CEO Eran Eshed, and based in Tel Aviv, Israel, Fairtility Ltd is a developer of in vitro fertilization (IVF) solutions using AI. In May 2022, Fairtility Ltd raised USD 15 million in series A funding led by new investor Gurnet Point Capital, along with investor Nacre Capital.

Fairtility Ltd provides CHLOE EQ™ (Cultivating Human Life through Optimal Embryos), which is an Embryo Quality Assessment Assistant that provides In vitro fertilization (IVF) solutions by analyzing the biological data of the system's embryo assessment and producing data-driven embryo quality assessment for pregnancy and less number of IVF cycles using artificial intelligence and big data. The company also develops KID+TM software that provides information related to predictions from fertilization time to the Blastocyst stage.

The company plans to use the funding to further develop its AI platform to improve IVF outcomes embryo quality assessment assistant CHLOE EQ™.

## Funding rounds

- Series A, May 23, 2022, $15M — Gurnet Point Capital, Nacre Capital

## Investors

- Gurnet Point Capital (https://capitalatlas.ai/funds/gurnet-point-capital) — Series A
- Nacre Capital (https://capitalatlas.ai/funds/nacre-capital) — Series A
